Navigation Links
Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information
Date:10/17/2007

Landmark Meeting Dec. 6, 2007 to Address FDA's Next Big Challenge

WASHINGTON, Oct. 17 /PRNewswire-USNewswire/ -- Is the Food and Drug Administration effectively communicating risk/safety information on drugs and devices to physicians and the public?

That's a key question a panel of experts will discuss and debate at a landmark Colloquium, Communicating Risk/Safety Information: How FDA Is Meeting the Challenge, sponsored by the Food and Drug Law Institute (FDLI), Dec. 6, 2007, in Washington, D.C.

This meeting is the third in a series of colloquia sponsored by FDLI. Under its new strategic direction, FDLI is committed to using the Colloquium series as a neutral forum to address the legal, regulatory, policy and practical implications of technological innovations affecting the food and drug industry.

As the public becomes more concerned about whether it's safe to take -- or stop -- their medications, FDA is making risk communication a top priority. The agency is forming an advisory committee on communication and implementing new Congressional requirements on risk evaluation. But it's unclear what that means for those who must deal with adverse events and contraindications every day.

Colloquium attendees will receive:

> Results of a study on how FDA handled the antidepressant drug controversy;

> Analysis of the new risk evaluation and mitigation strategy (REMS) requirements;

> Tips on developing world-class risk/safety and communications plans;

> Vital information on FDA's new Risk Communications Advisory Committee;

> An inside look at FDA's overall from communications strategy from its Deputy Commissioner and Chief Medical Officer Janet Woodcock, M.D.; and

> Excerpts from FDA's Response to the IOM's Report on Drug Safety.

The expert panel includes:

> Janet Woodcock, Deputy Commissioner & Chief Medical Officer, FDA;

> Randall W, Lutter, Deputy Commissioner for Policy & Planning, FDA;

> Stuart M. Pape, Managing Partner, Patton Boggs;

> Robert Dormer, Partner, Hyman Phelps & McNamara;

> Grace-Marie Turner, President, Galen Institute;

> Susan Newberry, Senior Vice President, Director, D.C Healthcare Practice,

Ketchum Communications; and

> Kelly Posner, Associate Professor, Columbia University.

Registration is $295 for FDLI members, $395 for non-members. Attendance is limited, so registrants are strongly urged to sign up early.

To register, visit http://fdli.org or call (800) 956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.


'/>"/>
SOURCE Food & Drug Law Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Hundred million dollar gift for malaria institute
2. Magsaysay Award for Dr.Shanta from Chennai Cancer Institute
3. Ontario Institute for Cancer Research is funded $142 million
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
6. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
7. Georgia Institute of Technology develops doppler Vein finder
8. Germany Institutes Tough Measures To Tackle Bird Flu
9. MoH Considering Hiking Fees, Private Institutes Are Worried
10. Business model for Liver Institute cleared by Delhi Cabinet
11. Government to Open More Pharma Institutes Across India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... and commercial support services market) has entered into an agreement on September 1, ... , The PGSD is the first private Dental School to launch an online, ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since ... been receiving positive feedback from customers trying the product for the first time, and ... Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk ...
(Date:9/20/2017)... ... 2017 , ... Medicare doesn’t have the authority to negotiate ... their prescription drugs, according to a new comparison of drug plans by ... there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare policy ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's ... Ezekiel's Plan for Freedom from ADDICTION” is the creation of published author, Bill ... of addiction and homeless services, including more than a decade of addiction to ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a fascinating depiction ... move the readers one step closer to God. “Psalms of Humidity” is the creation ... that have been made within his life are the very same things that have ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... Sept. 5, 2017  Xyntek Inc. has announced another milestone in their continued ... office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 West Adams Street, ... ... regionally. ...
(Date:9/5/2017)... Sept. 5, 2017  Just 18 months after its ... pleased to announce the appointment of three new senior ... , Dominic Jones-Phillips and James Wright ... Tammy Wynne ... market access writers. She has over ten years, experience ...
(Date:9/1/2017)... , Sept. 1, 2017 Michael ... Solutions, Inc , highlights opportunities for growth in his ... report that Marlin Equity is seeking a buyer for ... annual award-winning 22-year-old healthcare solutions Value Added Reseller and ... "As the healthcare market ...
Breaking Medicine Technology: